S, A., S, H., S, G., B, G., Y, C., MD, M., . . . P, S. (2024). TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature communications, 15(1), 5291. https://doi.org/10.1038/s41467-024-49189-x
Chicago Style (17th ed.) CitationS, Anandhan, et al. "TSG-6+ Cancer-associated Fibroblasts Modulate Myeloid Cell Responses and Impair Anti-tumor Response to Immune Checkpoint Therapy in Pancreatic Cancer." Nature Communications 15, no. 1 (2024): 5291. https://doi.org/10.1038/s41467-024-49189-x.
MLA (9th ed.) CitationS, Anandhan, et al. "TSG-6+ Cancer-associated Fibroblasts Modulate Myeloid Cell Responses and Impair Anti-tumor Response to Immune Checkpoint Therapy in Pancreatic Cancer." Nature Communications, vol. 15, no. 1, 2024, p. 5291, https://doi.org/10.1038/s41467-024-49189-x.